Digital cognition plus plasma p‐Tau217 and Aβ42/40 powerfully predict Alzheimer's progression

Abstract INTRODUCTION Alzheimer's disease is characterized by amyloid‐β (Aβ) and tau accumulation. Identifying individuals with rapid proteinopathy progression is crucial for timely intervention and trial enrichment. METHODS We analyzed longitudinal data from 456 Alzheimer's Disease Neuroimaging Ini...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Ahmet Begde, Yi Yang, Vanessa Raymont, James B. Rowe, Dean Palejev, Dishaa Sinha, Matthew Bennett, Rachel Brohier, Hannah Rome‐Hall, Ivan Koychev, for the Alzheimer's Disease Neuroimaging Initiative
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2026-01-01
Colecção:	Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Assuntos:	amyloid blood biomarkers digital cognitive assessment phosphorylated tau positron emission tomography p‐tau217
Acesso em linha:	https://doi.org/10.1002/dad2.70281
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!